Pharma Stocks
-
A Look at Elanco Animal Health’s Valuation After Securing FDA Emergency Use Nod for Credelio
Elanco Animal Health (NYSE:ELAN) just secured the first Emergency Use Authorization from the U.S. FDA for Credelio to treat New…
Read More » -
The pullback in China’s biopharmaceutical stocks presents an attractive buying opportunity, with CSPC Pharmaceutical (01093.HK) and Sinopharm Group (01099.HK) as preferred picks.
The CLSA report notes that China’s biotechnology and innovative pharmaceuticals industry has experienced volatility, driven by previous price increases leading…
Read More » -
3 Healthcare Stocks That Are Screaming Deals Right Now
Key Points DaVita’s recession-resistant business is growing internationally, but shares continue to trade at a heavily discounted valuation. Merck could…
Read More » -
Phathom Pharmaceuticals Stock (PHAT) Opinions on Phase 3 VOQUEZNA Study Results
By: Quiver DiscussionTracker Posted: 2 hours ago / Oct. 26, 2025 2:02 p.m. UTC VOQUEZNA Data Sparks Interest: Recent chatter on…
Read More » -
BofA Securities Lifts Amylyx Pharmaceuticals Inc. (AMLX) Price Target Amid Bolstered Balance Sheet
Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of billionaire Steve Cohen’s small-cap stock picks with huge upside potential. On October 3,…
Read More » -
Examining Bristol-Myers Squibb Shares After Steep 22.8% Drop and Clinical Trial Updates
If you’re eyeing Bristol-Myers Squibb and wondering whether now is the time to act, you’re not alone. There’s been plenty…
Read More » -
Is Progress on Cancer Drug Candidates and Big Pharma Partnerships Altering the Investment Case for ORIC Pharmaceuticals (ORIC)?
ORIC Pharmaceuticals has attracted attention after advancing its cancer drug candidates, ORIC-114 and ORIC-944, into Phase 1b studies and announcing…
Read More » -
Assessing Ascletis Pharma (SEHK:1672) Valuation After Strong Share Price Surge
Ascletis Pharma (SEHK:1672) recently closed at HK$9.12, catching the attention of investors who are gauging its performance over the month…
Read More » -
ANI Pharmaceuticals (ANIP): What Recent Momentum Means for Its Valuation
ANI Pharmaceuticals (ANIP) shares have been on the move lately, drawing attention from investors examining the company’s long-term performance and…
Read More » -
EMA Committee’s Positive Opinion on PYRUKYND Might Change The Case For Investing In Agios Pharmaceuticals (AGIO)
Agios Pharmaceuticals recently announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion…
Read More »
